Status:
COMPLETED
A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this clinical research study is to learn if a paclitaxel-cisplatin combination regimen given in the neoadjuvant setting is active in locally advanced head and neck cancer. the safety of...
Eligibility Criteria
Inclusion
- Locally advanced, Stage II-IV (except M1), hand and neck cancer
- \> = 1 measurable lesion
- not been previously treated for head and neck cancer
Exclusion
- history of another malignancy
- organ allografts
- pre-exiting neuropathy \> = CTC grade 2
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00337532
Start Date
May 1 2005
End Date
June 1 2007
Last Update
February 4 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Insitution
Seoul, South Korea
2
Local Institution
Seoul, South Korea